Retraction Note: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin

Affiliations

• ¹ Department of Surgery, Center for Bioengineering and Tissue Regeneration, University of California-San Francisco, San Francisco, CA, USA.
• ² Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA, USA.
• ³ Department of Pathology, University of California-San Francisco, San Francisco, CA, USA.
• ⁴ Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
• ⁵ Department of Surgery, Center for Bioengineering and Tissue Regeneration, University of California-San Francisco, San Francisco, CA, USA. Valerie.Weaver@ucsfmedctr.org.
• ⁶ Department of Anatomy, Bioengineering and Therapeutic Sciences, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, USA. Valerie.Weaver@ucsfmedctr.org.